Eiger BioPharmaceuticals Inc (EIGR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

2155 PARK BOULEVARD PALO ALTO, CA 94306

Celladon Corporation provides biotechnology products. The Company develops and distributes novel therapies for treatment of heart failure, diabetes, and neurodegenerative diseases.

Data based on most recent fiscal year report
Market Cap347.41 Million Shares Outstanding24.5 Million Avg Volume222.076 Thousand
1-Yr BETA vs S&P TR1.035 Current Ratio10.16 Quick Ratio10.16
View SEC Filings from EIGR instead.

Funds Holding EIGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EIGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments